✦ LIBER ✦

Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

✍ Scribed by M. Wallace; R. L. Rauck; D. Moulin; J. Thipphawong; S. Khanna; I. C. Tudor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose Conversion and Titration with a Nov

✍ Mark Palangio; Donald W Northfelt; Russell K Portenoy; Daniel Brookoff; Ralph T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 395 KB

A Randomized Study to Demonstrate Noninf

✍ Heinrich Binsfeld; Leszek Szczepanski; Sandra Waechter; Ute Richarz; Rainer Saba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

PSY9 BUDGET IMPACT OF THE USE OF OROS® H

✍ J Fleischmann; G Bergman; G Verkuijlen; A Lam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Results of a Double-blind, Placebo-contr

✍ Richard Rauck; Ronald Rapoport; John Thipphawong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

Extended-Release, Once-Daily Morphine (A

✍ Sumeet S. Panjabi; Ravi S. Panjabi; Marvin D. Shepherd; Kenneth A. Lawson; Micha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

A Review of Duloxetine 60 mg Once-Daily

✍ Joseph V. Pergolizzi Jr; Robert B. Raffa; Robert Taylor Jr; Gabriel Rodriguez; S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB